Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study.
von Gruenigen, Vivian E
Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study. [electronic resource] - Anti-cancer drugs Aug 2012 - 724-30 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1473-5741
10.1097/CAD.0b013e32835396d4 doi
Adult
Aged
Aged, 80 and over
Anemia--chemically induced
Cohort Studies
Diarrhea--chemically induced
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Maximum Tolerated Dose
Middle Aged
Neutropenia--chemically induced
Ovarian Neoplasms--drug therapy
Topoisomerase I Inhibitors--therapeutic use
Topotecan--therapeutic use
Uterine Neoplasms--drug therapy
Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study. [electronic resource] - Anti-cancer drugs Aug 2012 - 724-30 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1473-5741
10.1097/CAD.0b013e32835396d4 doi
Adult
Aged
Aged, 80 and over
Anemia--chemically induced
Cohort Studies
Diarrhea--chemically induced
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Maximum Tolerated Dose
Middle Aged
Neutropenia--chemically induced
Ovarian Neoplasms--drug therapy
Topoisomerase I Inhibitors--therapeutic use
Topotecan--therapeutic use
Uterine Neoplasms--drug therapy